ANGEL RIVERO ROBLES: Open Payments
NPI 1467099820 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 37 payments from 15 companies in 2025. Trend: 2023 $592 · 2024 $910 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Lilly USA, LLC | 6 | $108 |
| Novo Nordisk Inc | 5 | $101 |
| PFIZER INC. | 3 | $85 |
| Gilead Sciences, Inc. | 3 | $57 |
| Amgen Inc. | 3 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Dexcom, Inc. | 1 | $27 |
| ViiV Healthcare Company | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, PREVNAR 20, FARXIGA, JARDIANCE, AZMIRO, OTEZLA.
Industry payments across TX — which companies pay providers there.
